A once-a-day pill that reduces levels of the stress hormone cortisol in the brain is offering hope to older people living with Alzheimer’s disease, with early trial results revealing it may slow progression of the disease by up to 30 per cent.
Emestedastat, developed under the brand name Xanamem, works by blocking production of cortisol in key areas of the brain linked to the progression of the disease.
The trial, involving 247 patients in Australia and the US with mild to moderate disease over a 36-week course of treatment, did not record a statistically significant benefit in the overall trial group.
However, participants aged over the median…
Read the full article at SMH.COM.AU










